Introduction
Periodic lateralized epileptiform discharges (PLEDs) in electroencephalography (EEG) and their etiopathogenesis, relation to seizures, prognostic implications including morbidity and mortality have been discussed by many authors. [1] [2] [3] [4] [5] [6] They can occur in acute and chronic cerebrovascular disorders (infarcts and hemorrhages), brain infections and inflammation (Herpes simplex encephalitis, La Crosse virus encephalitis, subacute sclerosing panencephalitis, Creutzfeldt-Jacob disease, neuro-dengue, neuro-tuberculosis, syphilis and neurocysticercosis), cerebral tumors, trauma, and metabolic dysfunction. [7] [8] [9] [10] [11] [12] PLEDs and bilateral independent periodic lateralized epileptiform discharges (BiPLEDs) have been considered by many as an ''indication for impending seizures'' which need aggressive management with anti-epileptic medications (AEDs). 13 We have previously described emergent EEG (eEEG) as ''any EEG done on an emergency basis''. 10 PLEDs occur in both emergent and non-emergent settings and forms 0.1-1% of the total EEGs in any established electrophysiology laboratory. 6, 10, 12 The available data on the incidence and prevalence of PLEDs among the eEEGs (ePLEDs) is sparse and variable. 10, 14 In patients diagnosed with epilepsy, whose serial EEGs show PLEDs, the management is not influenced by their presence. However, in an acute setting, the presence of PLEDs in eEEG has diagnostic and prognostic implications. Very few studies have looked into the long-term prognosis and seizure control in patients with ePLEDs which is of utmost importance to a treating clinician. Hence, we undertook the present study in patients having ePLEDs in their eEEG with the following objectives: 1) To critically analyze the clinical and demographic profile, etiology as well as the electrophysiological and imaging characteristics of patients with ePLEDs. 2) To elucidate the outcome with regards to seizure control and functional disability if any, in the long-term. 
Recording of EEG
All recordings were carried out on a 16-channel digital EEG acquisition system (NicVue, Nicolet-Viking, USA) with the scalp electrodes placed according to the International 10-20 system. Standard activation procedures were employed whenever possible. Response to pain and other physiological stimuli were recorded in patients with altered sensorium. All eEEGs were obtained for a minimum of 30 min. Whenever possible, both awake and sleep record was obtained and if required, irritable and unmanageable patients were sedated with non-benzodiazepine sedatives. All the EEGs with ePLEDs were analyzed by a senior epileptologist (AR) involved in the study.
Classification and definition of ePLEDs
1. ePLEDs -lateralized or focal, periodic or near-periodic spike, spike wave or sharp-wave complex persisting for !75% or whole of the recording. 2. eBiPLEDs -bihemispheric, asynchronous, periodic or nearperiodic spike, spike wave or sharp-wave complex in two hemispheres persisting for !75% or whole of the recording.
When multiple records were available, the first record with defined PLEDs or BiPLEDs was considered as ''the index EEG''.
Neuroimaging scans
Computerized tomography scan (CT, single slice (10 mm), GE, USA) and Magnetic Resonance Imaging (MRI, 1.5 T, Magnetom Avanto TIM, Seimens, USA) were reviewed in detail by scrutinizing the films of each patient. All patients had at least a single MRI done during the hospital stay. MRI was done according to an emergency protocol including T1 weighted images, T2 weighted images, and fluid attenuated inversion recovery sequences (FLAIR). Diffusion weighted imaging (DWI), apparent diffusion coefficient (ADC) and post-gadolinium contrast imaging were done if required. Although CT scan was available in majority of the patients, MRI was preferred for the evaluation of the degree and extent of involvement of brain parenchyma. The MRI findings were classified into five sub categories by the Neuroradiologist.
Grade 1: MRI did not reveal any abnormality in any of the scans taken during the acute phase of illness. Grade 2: Predominant gray-matter involvement, affecting less than or equal to two contiguous lobes of the same hemisphere. Grade 3: Predominant white-matter involvement, affecting less than or equal to two contiguous lobes of the same hemisphere. Grade 4: Both gray and white-matter involvement, affecting less than or equal to two contiguous lobes of the same hemisphere. Grade 5: Grey-matter or white-matter or both involved in more than two lobes of one or both hemispheres.
Outcome measures
The outcome parameters analyzed were: Glasgow coma scale (GCS), presence or absence of seizures at entry, discharge and follow-up, morbidity and mortality. Favorable outcome was defined as seizure freedom with or without antiepileptic drugs during follow-up. Unfavorable outcome was defined as the presence of any type of seizures during follow-up. All deaths occurring while in the hospital or after discharge from the hospital were noted. Various electro-clinical features, neuroimaging characteristics and etiological factors which adversely affected the outcome were analyzed. The long-term functional disability was assessed by Modified Rankin Scale (MRS). The scale runs from 0 to 6, running from perfect health without symptoms to death.
-No symptoms.
1 -No significant disability: Able to carry out all usual activities, despite some symptoms.
2 -Slight disability: Able to look after own affairs without assistance, but unable to carry out all previous activities.
3 -Moderate disability: Requires some help, but able to walk unassisted.
4 -Moderately severe disability: Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
5 -Severe disability: Requires constant nursing care and attention, bedridden, incontinent. 6 -Dead.
Statistical methods
The demographic data and variables were expressed using descriptive statistics as percentages, mean AE standard deviation, median and range. The Fisher's exact test, Chi-square test and Student's t test was used as appropriate. A p value 0.05 was taken as significant. All the statistical analysis were done by SPSS version 15.0 (SPSS Inc., Chicago, IL, U.S.A.).
Results

Electro-clinical characteristics of patients with ePLEDs
During the study-period, 17,346 EEGs were carried out, of which 1948 (11.2%) were eEEGs. After the preliminary search, 191 patient records with PLEDs were identified. One hundred and twelve records (58.6%) were excluded due to various reasons (53 in whom the initial report carried the diagnosis of PLEDs, but later review of the EEG and/or reports did not satisfy the criteria for PLEDs; 41 were duplicate records and in 18, neither the EEGs nor their reports were retrievable for later review). Out of 1948 eEEGs, ePLEDs were identified in 79 (4%) patients and were finally included in the study (see Fig. 1 ). Of the 79 patients, 63 (79.7%) had ePLEDs and 16 (20.3%) had eBiPLEDs respectively. Forty-five patients were males and 28 patients were children (below 18 years of age). The median age on admission in patients with ePLEDs and eBiPLEDs together was 26 years (range 4 months to 82 years) ( Table 1 ). The median GCS at admission was 11 (range 3-15) in patients with ePLEDs and 6 (range 3-15) in patients with eBiPLEDs. The most common symptom at presentation in patients with both ePLEDs and eBiPLEDs was altered sensorium (59, 74.7%) followed by seizures (34, 43%). Eight (10.1%) patients had no seizures at entry when their index EEG showed ePLEDs or eBiPLEDs. Twentyseven (34.1%) patients died during their first hospitalization and the mean duration of hospital stay was 25 days (range 1-160 days). Altered sensorium at onset was observed significantly more in patients with eBiPLEDs than in those with ePLEDs (Table 1 , p = 0.008). Seizures at presentation were more common in ePLEDs than eBiPLEDs (p = 0.04).
EEG features and seizure patterns in ePLEDs
The EEG features and seizure patterns in patients with ePLEDs are described in Table 2 . ePLEDs were most commonly seen in fronto-central and fronto-temporal regions (45, 63.38%) followed by centro-temporal and temporo-parieto-occipital regions (20, 28.16%) in patients with seizures. Poor background activity comprising of medium-high amplitude, polymorphic, theta-delta frequency (3-7 Hz) was noted in all the patients with seizures. The complexes were spike, spike-wave, or sharp-wave complexes. PLEDs at discharge from the hospital were seen in 12 (23%) patients after a mean hospital stay of 25 days (1-160 days). Though the data did not achieve statistical significance, 20% of patients with eBiPLEDs and 16% of ePLEDs in their index EEG had persistence of PLEDs at the time of discharge from the hospital ( Table 2) . Secondary generalized seizures occurred in 60 (84.5%) patients. Clustering of seizures were noted in 58 (73.4%) patients and 7 (9.8%) patients had epilepsia partialis continua (EPC). Status epilepticus (SE) at presentation was seen in 29 (40.8%) during the acute phase of illness, eight of whom expired during hospitalization. The mean duration of hospitalization was 25 days (1-160 days). Three patients presented with myoclonic status, two had complex partial status and rest had generalized status epilepticus. We treated patients with seizures, status epilepticus and acute neurological disorders as per the standard institutional protocol. In nine (26.4%) patients who presented with seizures and ePLEDs/ eBiPLEDs in their EEG, benzodiazepines (Lorazepam) were given to abort the seizures. Other patients (73.6%) needed further aggressive treatment for control of seizures during the hospital stay. Examples of ePLEDs and eBiPLEDs are shown in Fig. 2. 
Etiological association
The most common causal association was central nervous system infection and inflammation (35.4%), followed by stroke (32.9%) and metabolic encephalopathy in 9 patients (11.4%, hyponatremia-3, hypoglycemia-3, hepatic encephalopathy-1, systemic infection with sepsis-2). CNS infection and inflammation were more common with eBiPLEDS than ePLEDs (p = 0.05). Among the CNS infections, herpes simplex encephalitis was proven in 7 (25%), and encephalitis of obscure etiology in another 13 (42.8%) patients. PLEDs in sub-acute sclerosing pan encephalitis, Creutzfeldt-Jacob disease, neuro-lupus and acute disseminated encephalomyelitis were observed in one each. Four patients with Rasmussen's encephalitis presented as seizures and EEG showed ePLEDs.
Comparison of children versus adults
The comparison of pediatric versus adult patients is shown in Table 3 . Seizure as the initial presentation was more commonly seen in children as compared to adults (64% versus 31%, p = 0.005). CNS infection and inflammation was frequently seen in pediatric age group as opposed to adults (50% versus 27%, p = 0.04). 
Neuroimaging characteristics
The imaging was normal (Grade 1) in 18 (22.8%) patients. Grade 2 lesions were present in 14 (17.7%) and Grade 3 lesions were noted in 12 (15.1%) patients. A comparison of the distribution of lesions in ePLEDs and eBiPLEDs group showed no significant difference (Table 1 and Fig. 3 ).
Outcome of patients with ePLEDs
The outcome of patients with ePLEDs is summarized in Table 4 . The mean duration of follow-up was 28 months (range 12-66 months). Thirty-four (65.4%) had persistent seizures (unfavorable outcome), either simple partial seizures (SPS) in 10 (29.4%) or complex partial seizures (CPS) in 24 (70.5%) during follow-up. The patients in eBiPLEDs group had poor seizure outcome as compared to ePLEDs (87.5% versus 61.4%). Out of 27 in-hospital deaths, 19 patients had eBiPLEDs and 8 had ePLEDs in their index EEG. Of the 13 patients who were lost for regular review and detailed clinical examination, 6 were reported to be dead and the rest had persistent seizures ascertained by telephonic/postal review. The median MRS grade was 2 and 3 for patients with ePLEDs and eBiPLEDs respectively (Table 4 ). Univariate analysis showed that impaired consciousness (p = 0.03), and seizures at presentation (p = 0.005) adversely affected the long-term seizure outcome. Patients with CNS infection or inflammation had persistent seizures during follow-up (p = 0.05) ( Table 5 ).
Discussion
PLEDs are one of the least characterized electrical patterns in EEG in terms of their neuropathological basis of occurrence. However, PLEDs have been considered as a very useful clinical marker of acute brain injury. Most of the existing studies consider emergent and non-emergent PLEDs as a single entity in the same cohort. We tried to address the importance of emergent PLEDs (ePLEDs) in a well characterized cohort of patients followed up in a systematic way.
The prevalence of ePLEDs in eEEG in the present study was 4% which is comparable to the existing data. 6, 15 The prevalence of ePLEDs and eBiPLEDs were 3.2% and 0.8% respectively. Seizures occurred in 90% of our patients and it has been reported in 58-100% in various patient populations. 6 The type of seizures associated with PLEDs were complex partial seizures (CPS), SPS, EPCs, secondary generalized seizures and SE. 5, 16, 17 The most common seizure type that we observed in our study was secondarily generalized seizures, seen in 84.5% of patients. In nine (26.4%) patients who presented with seizures and ePLEDs/ eBiPLEDs in their EEG, benzodiazepines was given to abort the seizures. Other patients (73.6%) needed further aggressive treatment for control of seizures during the hospital stay. This implies that a vast majority (more than 90%) who have ePLEDs/ BiPLEDs in their index EEG would require very careful monitoring and aggressive management of seizures. Despite offering adequate treatment with different combinations of AEDs with serial monitoring of EEGs, significant mortality occurred in both ePLEDs and eBiPLEDs group respectively (30 and 50%). This underscores the utility of performing emergent EEGs to identify ePLEDs and also the role of diligent management of acute seizures along with the underlying etiology causing ePLEDs. This further signifies that the severity of the underlying brain disease is the major determinant of mortality and that treatment with AEDs has little influence on outcome in patients with ePLEDs. CNS infection and inflammation was the most common etiology (35%), followed by stroke (32%) in patients with ePLEDs. The latter has been noted to be the most common etiology by many. 16, 17 Thirty-five percent of the cohort were children, in contrast to previous studies which could probably reflect a referral bias. Also, children are more vulnerable to CNS infection in this part of the world. Fifty percent of our children with ePLEDs had CNS infection and/or inflammation as compared to 27% of adults. More than twothird of children presented with seizures as compared to less than one-third of adults. Also, only 25% of children with ePLEDs died whereas, mortality was as high as 40% in adults despite active management. Even in children, it is probably the etiology that determines the final outcome rather than the mere presence of ePLEDs. This suggests the importance of performing serial emergent EEG in children with acute brain insults which is seldom undertaken in many intensive care units. A low prevalence of PLEDs have been described previously in children where only 88 NS PLEDs at discharge in survivors (n = 52) 9 (17.0%) 3 (20.0%) 12 (23%) NS a n = 71 (71/79 patients with ePLEDs had seizures at any time during their illness). * p by Chi-square test/Fisher exact test/t test, NS -not significant, CPS -complex partial seizures, SPS -simple partial seizure, EPC -epilepsia partialis continua, ePLEDsemergent periodic lateralized epileptiform discharges, eBiPLEDs -emergent bilateral independent periodic lateralized epileptiform discharge. routine EEG alone was taken into consideration at some point in time during the course of illness. 15, 18 Neuroimaging was normal in 23% of our patients. No correlation was observed between the grades of lesion which signifies the extent of involvement of brain parenchyma and the occurrence of ePLEDs. This further underscores the hypothesis that no anatomic site or degree of damage of cerebral parenchyma can be correlated with the occurrence or evolution of PLEDs. Despite having a severe degree of involvement (Grade 5) in neuroimaging (signifying both gray and white matter involvement of both hemispheres), the distribution of patients in ePLEDs and eBiPLEDs were not different and their outcome with regard to seizures also did not differ. However, it should be clearly understood that although the extent of neuroimaging abnormalities did not correlate with long-term seizure outcome, the underlying etiology may influence the prognosis.
Twelve patients had PLEDs persisting at discharge after a mean hospital stay of 25 days which is in congruence with the earlier 16-channel digital EEG in bipolar montage with eBiPLEDs comprising sharp waves over both the hemispheres occurring asynchronously with a variable periodicity ranging from 2 to 3.5 s with an associated background slowing comprising of low amplitude theta and faster frequencies over both posterior head regions (sensitivity 7 uv/mm). studies suggesting that PLEDs evolve and disappear over 4 weeks in more than two-third of patients. 16, 17, 19 PLEDs in many studies have been considered as a surrogate marker of early and high morbidity and mortality which ranges from 25 to 50%. In our study, 34% of our patients died either during follow-up or while in hospital. 6 Impaired consciousness (p = 0.03) and seizures at presentation (p = 0.005) predicted a poor long-term seizure outcome. Patients with CNS infection and/or inflammation had persistent seizures (p = 0.05) during follow-up. The mortality was higher in eBiPLEDs group as compared to ePLEDs group, although it did not reach statistical significance. The long-term functional disability was grater in patients with eBiPLEDs than ePLEDs. The mean MRS was 3 in patients with eBiPLEDs, whereas it was two in patients with ePLEDs at last follow-up. This signifies that more number of patients with eBiPLEDs needed assistance for all activities of daily living and had a poor quality of life as compared to those with ePLEDs. To our knowledge, this is the first study to look into the risk of long-term persistent seizures and predictors in patients presenting with ePLEDs. Our study demonstrated that impaired consciousness and seizures at presentation are adverse prognostic markers of longterm seizure outcome in patients with ePLEDs.
Conclusion
ePLEDs are a marker of clinical scenarios associated with major morbidity and significant mortality. They are associated with poor long term seizure outcome. Patients with ePLEDs often develop serious epileptic seizures during their subsequent hospital stay.
This calls for close monitoring of such patients and rigorous seizure management. Knowledge of the various predictors in a patient with ePLEDs in their EEG helps the treating neurologist in prognostication of individual cases. 
Table 5
Predictors of seizure outcome at last follow-up in patients with ePLEDs (N = 52).
Characteristics
Persistent seizures (n = 34) Seizure-free (n = 18) Total (n = 52) 
